Published on
August 25, 2026
- 08:22 GMT
CytoNiche Takes 3D RecomTrix™ Microcarriers Global with FDA and NMPA Regulatory Filings
SINGAPORE, August 25, 2026 /EINPresswire.com/ -- CytoNiche Biotech, a developer of advanced 3D cell manufacturing technologies, has expanded the global regulatory portfolio of its proprietary 3D RecomTrix™ recombinant collagen microcarriers (CW01), with …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Manufacturing
...
